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Impact of ketorolac on opioid consumption after open heart surgery
Laura Neubauer, Pharm.D.; Radhan B. Gopalani, Pharm.D., BCPS, BCCP; Kristen E. De Almeida, Pharm.D., BCCP;
Andrea Marr-Peralto, DNP, AGACNP, APRN

BACKGROUND
• Opioids are the most common analgesics used in the
postoperative period despite their potentially serious side
effects1,2
• The use of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
after open heart surgery for adjunctive pain control is
controversial given the potential risks of acute kidney
injury (AKI) with these agents
• Despite the FDA contraindication for use in patients
immediately following coronary artery bypass graft (CABG)
surgery, NSAIDs are commonly used in this setting with
one study showing ketorolac being the agent prescribed in
90% of cases1
• According to the current Baptist Health post open heart
order set, ketorolac use is not recommended in patients
with active bleeding, Scr >1.6 mg/dL, > 80yo, or recent
history of GI bleed

PURPOSE
To evaluate the use of ketorolac in the immediate 48 hours
after cardiac surgery at Baptist Hospital of Miami and South
Miami Hospital

CONCLUSIONS

RESULTS

RESULTS

Demographics

Avg. age, years (SD)
Age > 75 years – n (%)
Gender – male, n (%)
Outpatient use of opioids – n (%)
Outpatient use of adjuvant pain meds – n (%)
Non-Elective Procedure – n (%)
Avg. Scr on admission, mg/dL (SD)
Avg. Scr day of surgery, mg/dL (SD)
Avg. Scr 48h postop, mg/dL (SD)
OTHER RISK FACTORS FOR AKI
Use of CPB – n (%)
Dehydration postop (BUN:Scr > 20:1) – n (%)
Use of vasopressors postop – n (%)

Ketorolac
(n=22)
63.2 + 9.2
2 (9)
18 (81.8)
1 (4.5)
2 (9)
16 (73)
0.99 + 0.23
0.90 + 0.16
0.92 + 0.19

No Ketorolac
(n=45)
68.4 + 9.0
11 (24.4)
33 (73.3)
1 (2.2)
4 (8.9)
28 (62)
1.04 + 0.32
0.98 + 0.28
1.18 + 0.53

20 (90.9)
12 (54.5)
19 (86.4)

39 (86.7)
28 (62.2)
32 (71.1)

P-value
< 0.05
0.20
0.55
0.55
1.00
0.40
0.50
0.21
< 0.05
0.62
0.55
0.17

Primary Outcome:
‒ Opioid consumption in morphine milligram equivalents
(MME) within 48 hours after open heart surgery

• Patients who did not receive ketorolac had a significantly
higher rate of postoperative AKI (p<0.05), possibly due to the
significantly older population in this cohort; other risk factors
for AKI were similar between cohorts
• Use of ketorolac per the recommendations in the Baptist
Health open heart order set may have additionally
contributed to selection bias
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Retrospective
Small study duration and sample size
Selection bias
Pain scores could not be evaluated due to inconsistent
documentation

DISCUSSION
ANALGESICS RECEIVED WITHIN 48 HOURS POSTOP
Ketorolac
(n=22)
22 (100)
21 (95.5)
19 (86.4)
5 (22.7)
0
0
1 (4.5)

Analgesic – n (%)
Morphine
Acetaminophen IV
Oxycodone/Acetaminophen
Acetaminophen PO
Hydromorphone
Gabapentin
Tramadol

Secondary Outcomes:
‒ Incidence of AKI within 48 hours after open heart
surgery (↑ in Scr > 0.3 mg/dL in 48 hours)
‒ Opioid-induced adverse drug reactions (ADRs)

Controlling for Confounding Factors
‒ To control for selection bias, patients with baseline CKD
and those who received fentanyl (IV push or infusion)
during the immediate 48 hours postoperatively were
removed from the final analysis

• Morphine and oxycodone/acetaminophen were the most
commonly received opioids. Acetaminophen IV was the most
commonly received non-opioid analgesic

p-value= 0.11

Study Design: Multicenter, retrospective quality
improvement project

Exclusion Criteria:
‒ Pregnant at time of hospitalization

• There was no statistical difference in opioid consumption
between cohorts (p=0.11)

• A total of 3 opioid-induced ADRs resulting in treatment
discontinuation were reported (hallucinations, slight oversedation, and nausea/vomiting)

OPIOID CONSUMPTION WITHIN 48 HOURS POSTOP

METHODS
Inclusion Criteria:
‒ Adults ≥ 18 years of age
‒ Underwent open heart surgery (CABG, valvular
replacement, CABG/valvular surgery, aortic surgery)
performed between 1/1/2020 and 3/31/2020

• Baseline demographics were not statistically different
between cohorts except for age (p<0.05)

No Ketorolac
(n=45)
41 (91.1)
41 (91.1)
37 (82.2)
15 (33.3)
4 (8.9)
3 (6.7)
1 (2.2)

POSTOP INCIDENCE OF AKI
p-value < 0.05
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• Risk of postoperative AKI did not increase with ketorolac
o Observed statistically significant difference in AKI is not
clinically meaningful and is likely due to the patient
population under review
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Ketorolac

• Use of ketorolac in the immediate postoperative period did
not impact opioid consumption
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